IMAC Holdings Files 8-K with Material Agreement Update

TL;DR

IMAC Holdings signed a material definitive agreement on 9/4/25, filing an 8-K on 9/10/25.

AI Summary

IMAC Holdings, Inc. filed an 8-K on September 10, 2025, reporting on events that occurred on September 4, 2025. The filing includes information regarding a material definitive agreement, Regulation FD disclosures, and financial statements/exhibits. Specific details of the material definitive agreement are not provided in this excerpt.

Why It Matters

This 8-K filing indicates IMAC Holdings, Inc. has entered into a significant agreement, which could impact its business operations and financial standing.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could represent a significant change or risk for the company, but the specifics are not detailed in this excerpt.

Key Players & Entities

• IMAC Holdings, Inc. (company) — Registrant
• September 4, 2025 (date) — Earliest event reported
• September 10, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• 3401 Mallory Lane, Suite 100 Franklin, Tennessee 37067 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share BACK OTC Markets Group, I
• $420,000 — cancers. The maximum contract value is $420,000 with $175,000 payable upon execution an
• $175,000 — maximum contract value is $420,000 with $175,000 payable upon execution and the remainde

Filing Documents

• form8-k.htm (8-K) — 41KB
• ex10-1.htm (EX-10.1) — 5KB
• ex99-1.htm (EX-99.1) — 11KB
• ex99-1_001.jpg (GRAPHIC) — 3KB
• ex10-1_001.jpg (GRAPHIC) — 1230KB
• ex10-1_002.jpg (GRAPHIC) — 705KB
• ex10-1_003.jpg (GRAPHIC) — 1087KB
• ex10-1_004.jpg (GRAPHIC) — 195KB
• ex10-1_005.jpg (GRAPHIC) — 243KB
• 0001641172-25-027034.txt ( ) — 4992KB
• back-20250904.xsd (EX-101.SCH) — 3KB
• back-20250904_lab.xml (EX-101.LAB) — 33KB
• back-20250904_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 3KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 IMAC Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38797 83-0784691 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number) 3401 Mallory Lane , Suite 100 Franklin , Tennessee 37067 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (844) 266-4622 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share BACK OTC Markets Group, Inc. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 1.01 Entry into a Material Definitive Agreement. The information provided in Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 1.01. On September 4, 2025, Ignite Proteomics, LLC, a wholly owned subsidiary of IMAC Holdings, Inc. (the "Company"), entered into a Statement of Work ("SOW") with Inova Health Care Services ("Inova") under their existing Master Services Agreement ("MSA"). Under the SOW, Ignite will analyze up to 600 tumor samples using its Reverse Phase Protein Array ("RPPA") technology to generate biomarker data across a panel of cancer-relevant proteins. Results will be provided to Inova's Molecular Tumor Board to support assessment of therapy response and resistance in gastrointestinal cancers. The maximum contract value is $420,000 with $175,000 payable upon execution and the remainder billed based on delivered reports. A copy of the Agreement is filed as Exhibit 10.1 to this Current Report. Item 7.01 Regulation FD Disclosure On September 10, 2025, the Company issued a press release announcing the collaboration, a copy of which is furnished as Exhibit 99.1 to this Current Report. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 99.1 Press Release dated September 10, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 10, 2025 IMAC HOLDINGS, INC. By: /s/ Faith Zaslavsky Name: Faith Zaslavsky Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR